Flexion Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.20 billion, with shareholders equity totaling $-82.38 million.
The company employs approximately 257 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Flexion Therapeutics Inc. reported $100.41 million in revenue, generating net income of $-100.73 million.
Key financial metrics include a P/E ratio of -11.89, a price-to-book (P/B) ratio of -14.54, and a trailing twelve-month dividend yield of 11.45%.
The company trades under the ticker FLXN.